Compare Cassava Sciences Inc (FLNA) vs Western Union Co (WU) Price & Performance

FLNA trades at $0.8157, down 6.77% today, with a bearish technical signal from moving averages. The company shows improving quarterly EPS trends, beating expectations in recent quarters, though it remains unprofitable with negative ROE and ROA. Recent FDA clearance for its epilepsy drug trial provides a positive catalyst. Analyst sentiment is bullish with 67% buy ratings.

The outlook hinges on clinical progress; upside exists if Phase 2a trials succeed, but high cash burn and lack of revenue pose significant risks. Investors should weigh the strong analyst support against the company's financial challenges and binary clinical outcomes.

Western Union (WU) trades at $6.11, down 0.49% on the day, with bearish technical signals and mixed earnings performance. The stock shows attractive valuation metrics with a P/E of 4.93 and P/S of 0.48, while maintaining strong profitability with 9.79% net margins. Recent developments include the pending Intermex acquisition and expansion of retail partnerships, though earnings misses in Q1 and Q2 2026 raise execution concerns. Cash flow trends show volatility with a $469M net outflow in 2025.

WU presents a value opportunity with deep valuation discounts but faces execution risks amid digital transformation. The $200M cost-cutting plan and Intermex acquisition offer potential upside if successfully implemented, while competitive pressures and integration challenges pose downside risks. Analyst consensus at $6.86 suggests modest upside from current levels, though the mixed rating distribution reflects uncertainty about the turnaround strategy.